The results revealed that SDS might target PPARα to regulate autophagy and apoptosis, enhancing immunity and alleviating inflammation, to exert preventive and therapeutic activities on NASH. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.